(Q24246291)

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Oral misoprostol vs. intravenous oxytocin for labor induction in women with prelabor rupture of membranes at term

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Cervical ripening with oral misoprostol at term

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Randomized comparison of oral misoprostol and oxytocin for labor induction in term prelabor membrane rupture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Safety and efficacy of misoprostol orally and vaginally: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Titrated oral compared with vaginal misoprostol for labor induction: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Prospective randomized clinical trial of inpatient cervical ripening with stepwise oral misoprostol vs vaginal misoprostol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Oral misoprostol for premature rupture of membranes at term

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Oral misoprostol or vaginal dinoprostone for labor induction: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Oral misoprostol for induction of labour at term: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Oral versus vaginal misoprostol for induction of labor: a double-blind randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Oral versus vaginal misoprostol for labor induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Oral misoprostol vs. placebo in the management of prelabor rupture of membranes at term

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

A comparison of various routes and dosages of misoprostol for cervical ripening and the induction of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Oral misoprostol versus intracervical dinoprostone for induction of labor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Oral and vaginal misoprostol compared with dinoprostone for induction of labor: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Ruptured membranes at term: randomized, double-blind trial of oral misoprostol for labor induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

The MisoPROM study: A multicenter randomized comparison of oral misoprostol and oxytocin for premature rupture of membranes at term

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Labour characteristics and uterine activity: misoprostol compared with oxytocin in women at term with prelabour rupture of the membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Misoprostol vs. oxytocin for induction of labor at term

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

A comparison between intravaginal and oral misoprostol for labor induction: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Comparison of oral and vaginal misoprostol for induction of labor at term: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

A comparison of 100 microg oral misoprostol every 3 hours and 6 hours for labor induction: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

A comparison of labor induction by oral and vaginal misoprostol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

A comparison of two dosage regimens of oral misoprostol for labor induction at term

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Active management of term prelabour rupture of membranes with oral misoprostol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Oral misoprostol (100 μg) versus vaginal misoprostol (25 μg) in term labor induction: a randomized comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

A randomised comparison of oral misoprostol and vaginal prostaglandin E2 tablets in labour induction at term

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Oral or vaginal misoprostol for induction of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

A comparison of oral and vaginal misoprostol for induction of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

A comparison of orally administered misoprostol with vaginally administered misoprostol for cervical ripening and labor induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

A randomized comparison of oral and intravaginal misoprostol for labor induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

A comparison of orally administered misoprostol to intravenous oxytocin for labor induction in women with favorable cervical examinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Pre-labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Titrated low-dose vaginal and/or oral misoprostol to induce labour for prelabour membrane rupture: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Oral misoprostol against vaginal dinoprostone for labor induction at term: a randomized comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Use of misoprostol on an outpatient basis for postdate pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Oral misoprostol versus intracervical prostaglandin E2 gel for active management of premature rupture of membranes at term

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrum after postpartum oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Uterine rupture associated with misoprostol labor induction in women with previous cesarean delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Membrane sweeping for induction of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Intracervical prostaglandins for induction of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Amniotomy alone for induction of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Misoprostol and illegal abortion in Rio de Janeiro, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Oral prostaglandin E2 for induction of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Vaginal misoprostol for cervical ripening and induction of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Amniotomy plus intravenous oxytocin for induction of labour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Extra-amniotic prostaglandin for induction of labour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Breast stimulation for cervical ripening and induction of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Castor oil, bath and/or enema for cervical priming and induction of labour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Nitric oxide donors for cervical ripening and induction of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Intravenous prostaglandin for induction of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Buccal or sublingual misoprostol for cervical ripening and induction of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Mifepristone for induction of labour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Use of misoprostol during pregnancy and Möbius' syndrome in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Homoeopathy for induction of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Acupuncture for induction of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Oestrogens alone or with amniotomy for cervical ripening or induction of labour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Misoprostol and the debate over off-label drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Oral misoprostol for induction of labour with a viable fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Induction of labor with oral misoprostol for premature rupture of membranes at term in women with unfavorable cervix: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

Intravenous oxytocin alone for cervical ripening and induction of labour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

7 January 2021

Cervical priming with oral misoprostol in pre-labor rupture of membranes at term

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

7 January 2021

Misoprostol and congenital malformations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

7 January 2021

Sublingual compared with oral and vaginal misoprostol for labor induction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

7 January 2021

Comparison of labor induction with misoprostol vs. oxytocin/prostaglandin E2 in term pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

7 January 2021

Oral misoprostol and intracervical dinoprostone for cervical ripening and labor induction: a randomized comparison

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

7 January 2021

Oral administration of misoprostol for labor induction: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

7 January 2021

A masked randomized comparison of oral and vaginal administration of misoprostol for labor induction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

7 January 2021

Oral or vaginal misoprostol administration for induction of labor: a randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

7 January 2021

Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

7 January 2021

Labour characteristics and uterine activity: misoprostol compared with oxytocin in women at term with prelabour rupture of the membranes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

7 January 2021

The routine use of oxytocin after oral misoprostol for labour induction in women with an unfavourable cervix is not of benefit

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001338.PUB2

7 January 2021